Chandana B Herath Selected Research

Experimental Liver Cirrhosis

8/2021

Anti-Fibrotic and Anti-Angiogenic Activities of Osbeckia octandra Leaf Extracts in Thioacetamide-Induced Experimental Liver Cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chandana B Herath Research Topics

Disease

18	Fibrosis (Cirrhosis) 01/2022 - 09/2007
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 04/2014
5	Portal Hypertension 01/2022 - 02/2013
4	Non-alcoholic Fatty Liver Disease 01/2022 - 04/2014
4	Liver Diseases (Liver Disease) 08/2021 - 09/2007
4	Inflammation (Inflammations) 01/2018 - 08/2012
3	Fatty Liver 01/2022 - 04/2014
1	Hyperglycemia 01/2022
1	Experimental Liver Cirrhosis 08/2021
1	COVID-19 12/2020
1	Sclerosing Cholangitis 12/2019
1	Liver Failure 12/2019
1	Disease Progression 10/2019
1	Hypotension (Low Blood Pressure) 01/2019
1	Trypanosomiasis 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 10/2013
1	Amyloidosis 10/2013
1	Virus Diseases (Viral Diseases) 10/2013
1	Acute Liver Failure (Fulminant Hepatic Failure) 10/2013
1	Chronic Hepatitis C 10/2013
1	Hemorrhage 02/2013
1	Neoplasms (Cancer) 04/2010
1	Neoplasm Metastasis (Metastasis) 04/2010
1	Colorectal Neoplasms (Colorectal Cancer) 04/2010
1	Hepatitis C 09/2009
1	Prostatic Neoplasms (Prostate Cancer) 11/2004
1	Ovarian Cysts (Ovarian Cyst) 02/2002
1	Cysts 02/2002

Drug/Important Bio-Agent (IBA)

9	angiotensin I (1-7)IBA 02/2021 - 09/2007
7	Angiotensin IIIBA 02/2021 - 09/2007
6	AngiotensinsIBA 01/2022 - 09/2009
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2021 - 07/2009
5	Angiotensin-Converting Enzyme 2IBA 12/2019 - 09/2007
4	Peptides (Polypeptides)IBA 02/2021 - 09/2009
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2013
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 01/2019
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020 - 09/2008
3	Type 1 Angiotensin ReceptorIBA 01/2019 - 04/2010
2	Pharmaceutical PreparationsIBA 12/2019 - 01/2018
2	Advanced Glycation End ProductsIBA 10/2019 - 04/2014
2	C.I. direct red 80IBA 09/2016 - 09/2009
2	Dietary Advanced Glycation End ProductsIBA 09/2016 - 04/2014
2	CollagenIBA 09/2016 - 09/2009
2	Carbon Tetrachloride (Tetrachloromethane)IBA 09/2015 - 01/2015
1	CholesterolIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 08/2021
1	Thioacetamide (Thioacetamid)IBA 08/2021
1	EnzymesIBA 02/2021
1	Angiotensin IIBA 02/2021
1	SARS-CoV-2 spike proteinIBA 12/2020
1	diminazene aceturateIBA 01/2018
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 09/2016
1	Choline (Choline Chloride)IBA 09/2015
1	Therapeutic UsesIBA 09/2015
1	Methionine (L-Methionine)FDA Link 09/2015
1	Vasoconstrictor AgentsIBA 01/2015
1	LigandsIBA 01/2015
1	AVE 0991IBA 01/2015
1	Superoxides (Superoxide)IBA 04/2014
1	NADP (NADPH)IBA 04/2014
1	Triglycerides (Triacylglycerol)IBA 04/2014
1	Messenger RNA (mRNA)IBA 10/2013
1	GTP-Binding Proteins (G-Protein)IBA 10/2013
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 01/2013
1	Captopril (Capoten)FDA LinkGeneric 04/2010
1	salicylhydroxamic acid (SHAM)IBA 04/2010
1	Hydroxyproline (4 Hydroxyproline)IBA 09/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2009
1	Connective Tissue Growth FactorIBA 09/2009
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 09/2008
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2004
1	Follicle Stimulating Hormone (Follitropin)FDA Link 02/2002
1	Inhibins (Inhibin)IBA 02/2002
1	inhibin-alpha subunitIBA 02/2002

Therapy/Procedure

9	Therapeutics 01/2022 - 09/2015
3	Ligation 09/2015 - 09/2009
2	Drug Therapy (Chemotherapy) 02/2013 - 09/2008
1	Glycemic Control 01/2022
1	Intraperitoneal Injections 12/2019
1	Liver Transplantation 10/2013